Post operative radiation therapy in endometrial carcinoma : reducing overtreatment and improving quality of life

By Remi A. Nout. 2013

712 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/b5682e268a849617efc6d9307816da695b612ec4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. N. Colombo
2. C. Sessa
3. E. Stelloo
4. Carien L. Creutzberg
5. Jonathan A. Ledermann
6. T. Bosse
7. M. Mirza
8. A. González-Martín

Citations in the corpus

• Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts (2016, background): “The design and clinical results of both randomized trials havebeenpublishedpreviously (4, 7).”
• ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer (2015, result): “The randomised PORTEC-2 trial included only patients with the high-intermediate-risk factors defined in PORTEC-1, and showed that vaginal brachytherapy provided excellent vaginal control compared with EBRT, and had a more favourable toxicity and quality of life profile.(126) These results have been ”